PEOPLE - Angiotech Pharmaceuticals makes appointment:
This article was originally published in Clinica
Executive Summary
Canadian company Angiotech Pharmaceuticals has appointed Dr Thomas Spencer of Pharmetrix in the US chief scientific officer. Angiotech uses its technology to reformulate the anticancer drug, paclitaxel, into medical device coatings, systemic treatments and topical gels.